Global Sleep Apnea Market Outlook 2020

  • ID: 3600436
  • Report
  • Region: Global
  • 95 pages
  • RNCOS E-Services Private Limited
1 of 5
Technologically Advanced Therapies Fueling the Sleep Apnea Therapeutic Devices Market

FEATURED COMPANIES

  • BMC Medical Co., Ltd.
  • ResMed Inc.
  • SomnoMed
  • MORE
Sleep apnea is a common disorder that occurs when a person’s breathing is interrupted during sleep. Sleep apnea is a chronic condition and often largely goes undiagnosed. Sleep apnea can be further differentiated into three types: obstructive sleep apnea, central sleep apnea, and complex/mixed sleep apnea. Obstructive sleep apnea occurs when the muscles relax during sleep, causing soft tissue in the back of the throat to collapse and block the upper airway. It is also the most common type of sleep apnea seen in people. An untreated sleep apnea can increase the risk of high blood pressure, heart attack, stroke, obesity, and diabetes. It also increases the risk of, or worsen, heart failure and the chances of having work-related or driving accidents.

According to a new analysis in “Global Sleep Apnea Market Outlook 2020” report, the global sleep apnea therapeutic devices market is anticipated to grow at a CAGR of 7.5% during the forecast period (2015-2020). The market growth is expected mainly due to the growing incidences of sleep-related breathing disorders, increasing awareness about sleep apnea coupled with the rising incidences of obesity.

According to the analysis, conventional Positive Airway Pressure (PAP) devices continue to dominate the market in terms of the therapeutic devices used for the treatment of sleep apnea; however it is the oral appliances segment that is expected to witness the maximum growth in the coming years. This high growth is likely to be driven by the fact that oral appliancesare small and discreet and easily potable as compared to the conventional devices.

Also, in terms of application of the devices, obstructive sleep apnea is most commonly observed amongst all the three types of sleep apnea; however, central sleep apnea has an increasing incidence in patients with heart diseases. In terms of geography, North America is the largest market forsleep apnea therapeutic devices market, but it is the Asia Pacific market, which is expected to witness the highest growth, largely due to improving medical facilities, growing awareness, and increasing focus of various players in this region.The report provides information on the current scenario, market outlook on the basis of the products available, application and geography, and the future forecasts on all prominent segments of the industry till 2020.

The report also provides details about innovative therapies that are now increasingly available in the market, as alternatives to the conventional PAP–based therapy. The later part of the report focuses on competitive analysis of the key market players, in terms of their market share and their product offerings. Major players operating in this market include Philips Respironics, ResMed, Fisher, and Paykel, among others. The competitive analysis is done at each player level, including their recent developments. To provide a thorough understanding of each player’s business model, the player’s current and historical financials have been analysed. On the whole, the study included in the report provides a detailed market overview, current and future scenario, and industry trends, which will likely generate key interest in investors thinking about joining the industry.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • BMC Medical Co., Ltd.
  • ResMed Inc.
  • SomnoMed
  • MORE
1. Analyst View

2. Research Methodology

3. Sleep Apnea - An Introduction

4. Market Dynamics
4.1 Drivers
4.1.1 Increasing Prevalence of Sleep Related Breathing Disorders (SBD)
4.1.2 Growing Awareness of Sleep Apnea
4.1.3 Increasing Investment in Sleep Apnea Market
4.1.4 Technological Advancements
4.1.5 Rising Incidence of Obesity
4.2 Challenges
4.2.1 Poor Patient Compliance with CPAP Devices
4.3 Opportunities
4.3.1 Emerging Market Offering Significant Growth Opportunity
4.3.2 Colossal Undiagnosed Sleep Apnea Patient Pool

5. Sleep Apnea Therapeutic Devices Market Market Overview
5.1 Current Market Size and Future Growth

6. Sleep Apnea Therapeutic Devices Market, By Product
6.1 Introduction
6.1.1 Positive Airway Pressure Devices
6.1.1.1 Continuous Positive Airway Pressure Devices
6.1.1.2 Bilevel Positive Airway Pressure Devices
6.1.1.3 Auto Positive Airway Pressure Devices
6.1.1.4 Adaptive Servo – Ventillation Devices
6.1.2 Facial Interfaces
6.1.2.1 Nasal Masks
6.1.2.2 Nasal Pillow Masks
6.1.2.3 Full Face Masks
6.1.2.4 Others
6.1.3 Oral Appliances
6.1.3.1 Mandibular Advancement Devices
6.1.3.2 Tongue Retaining Devices
6.1.4 Accessories
6.1.4.1 Mask Accessories
6.1.4.2 Device Accessories

7. Sleep Apnea Therapeutic Devices Market, By Application
7.1 Introduction
7.1.1 Obstructive Sleep Apnea
7.1.2 Central Sleep Apnea
7.1.3 Complex/Mixed Sleep Apnea

8. Sleep Apnea Therapeutic Devices Market, By Region
8.1 Introduction
8.1.1 North America
8.1.2 Europe
8.1.3 Asia Pacific

9. Innovative Therapies for Sleep Apnea
9.1 Neurostimulators
9.2 Intra – Oral Devices
9.3 Others

10. Porter’s Five Forces Analysis

11. Competitive Analysis
11.1 Competitive Benchmarking
11.2 Market Share Assesment

12. Key Player Analysis
12.1 BMC Medical Co., Ltd.
12.2 CareFusion Corporation (A Subsidiary of Becton, Dickinson And Company)
12.3 Drive DeVilbiss Healthcare
12.4 Fisher & Paykel Healthcare Corporation Limited
12.5 Philips Healthcare (A Division of Koninklijke Philips N.V.)
12.6 ResMed Inc.
12.7 SomnoMed
12.8 Weinmann Geräte für Medizin GmbH + Co. KG
12.9 Whole You, Inc. (A Subsidiary of Mitsui Chemicals)

List of Tables
Table 6-1: Global - Sleep Apnea Therapeutic Devices Market by Product (Million US$), 2015
Table 7-1: Global - Sleep Apnea Therapeutic Devices Market by Application (Million US$), 2015
Table 8-1: Global - Sleep Apnea Therapeutic Devices Market by Region (Million US$), 2015
Table 11-1: Competitive Benchmarking
Table 12-1: Becton, Dickinson and Company - Key Financials (Million US$), 2012-2014
Table 12-2: Fisher & Paykel Healthcare Corporation Limited - Key Financials (Million US$), 2013-2015
Table 12-3: Koninklijke Philips N.V. - Key Financials (Million US$), 2012-2014
Table 12-4: ResMed Inc. - Key Financials (Million US$), 2013-2015
Table 12-5: Somnomed - Key Financials (Million US$), 2013-2015
Table 12-6: Mitsui Chemicals - Key Financials (Million US$), 2012-2014

List of Figures
Figure 3-1: Prevalance of Sleep Apnea in Comorbidities
Figure 5-1: Global - Sleep Apnea Therapeutic Devices Market (Million US$), 2015-2020
Figure 6-1: Global - Sleep Apnea Therapeutic Devices Market by Product (%), 2015
Figure 6-3: Global - PAP Devices Market for Sleep Apnea (Million US$), 2015-2020
Figure 6-4: Global - CPAP Devices Market for Sleep Apnea (Million US$), 2015-2020
Figure 6-5: Global - BiPAP Devices Market for Sleep Apnea (Million US$), 2015-2020
Figure 6-6: Global - APAP Devices Market for Sleep Apnea (Million US$), 2015-2020
Figure 6-7: Global - ASV Devices Market for Sleep Apnea (Million US$), 2015-2020
Figure 6-8: Global - Facial Interfaces Market for Sleep Apnea (Million US$), 2015-2020
Figure 6-9: Global - Nasal Masks Market for Sleep Apnea (Million US$), 2015-2020
Figure 6-10: Global - Nasal Pillow Masks Market for Sleep Apnea (Million US$), 2015-2020
Figure 6-11: Global - Full Face Masks Market for Sleep Apnea (Million US$), 2015-2020
Figure 6-12: Global - Other Masks Market for Sleep Apnea (Million US$), 2015-2020
Figure 6-13: Global - Oral Appliances Market for Sleep Apnea (Million US$), 2015-2020
Figure 6-14: Global - Mandibular Advancement Devices Market for Sleep Apnea (Million US$), 2015-2020
Figure 6-15: Global - Tongue Retaining Devices Market for Sleep Apnea (Million US$), 2015-2020
Figure 6-16: Global - Accessories Market for Sleep Apnea (Million US$), 2015-2020
Figure 6-17: Global - Mask Accessories Market for Sleep Apnea (Million US$), 2015-2020
Figure 6-18: Global - Device Accessories Market for Sleep Apnea (Million US$), 2015-2020
Figure 7-1: Global - Sleep Apnea Therapeutic Devices Market by Application (%), 2015
Figure 7-3: Global - OSA Market (Million US$), 2015-2020
Figure 7-4: Global - CSA Market (Million US$), 2015-2020
Figure 7-5: Global - Complex Sleep Apnea (Million US$), 2015-2020
Figure 8-1: Global - Sleep Apnea Therapeutic Devices Market by Region (%), 2015
Figure 8-3: North America - Sleep Apnea Therapeutic Devices Market (Million US$), 2015-2020
Figure 8-4: Europe - Sleep Apnea Therapeutic Devices Market (Million US$), 2015-2020
Figure 8-5: Asia Pacific - Sleep Apnea Therapeutic Devices Market (Million US$), 2015-2020
Figure 10-1: Porter’s Five Forces Analysis
Figure 11-1: Global - Market Share Assesment for Key Players (%)
Figure 12-1: Fisher & Paykel Healthcare Corporation Limited - Break up of Revenue by Product Group (%), 2015
Figure 12-2: Philips Healthcare - Break up of Revenue by Reportable Business Segment (%), 2014
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • BMC Medical Co., Ltd.
  • ResMed Inc.
  • SomnoMed
  • MORE
According to a new research report entitled, “Global Sleep Apnea Market Outlook 2020”, innovation and technological advancements are driving the sleep apnea therapeutic devices market.

With the growing non compliant PAP therapy patient population, there is an increasing interest in the development of new alternative devices and procedures that allow the treatment of OSA.

These novel technologically advanced therapies have been categorized into two segment, namely, Neurostimulators and Intra – Oral Devices. The Neurostimulator devices activate the hypoglossal nerve, which is responsible for the movement of muscles in the tongue, has been used as an alternative therapy for OSA sufferers. These include, Inspire Upper Airway Stimulation and the THN Sleep Therapy by ImThera. The Inspire therapy developed by Inspire Medical Systems consists of a breathing sensor and a stimulation lead, powered by a small battery. This therapy is FDA approved and proven to be effective in sleep apnea treatment. The THN Sleep Therapy by ImThera Medical consists of an innovative, CPAP-alternative, fully implantable device called the Aura6000. The device is currently available for use only in Europe.

The intra oral devices are designed to displace tongue, oral tissue and/or the jaw, allowing the maintenance of an open airway. They are often used to treat mild OSA. These include, SomnoDent and Provent Sleep Apnea Therapy. SomnoDent, is a custom-made oral appliance for the treatment of mild to moderate OSA and is approved for use since 1996. The Provent Therapy by Theravent utilizes nasal EPAP (expiratory positive airway pressure) to treat all levels of severity of OSA.

The alternative therapies are attractive to patients because they are small and discrete, do not emit noise, and are more easily integrated into the patient’s normal life. They are more easily portable than a PAP-based therapy, enabling more flexibility for the patient
Note: Product cover images may vary from those shown
5 of 5
- BMC Medical Co., Ltd.
- CareFusion Corporation (A Subsidiary of Becton, Dickinson And Company)
- Drive DeVilbiss Healthcare
- Fisher & Paykel Healthcare Corporation Limited
- Philips Healthcare (A Division of Koninklijke Philips N.V.)
- ResMed Inc.
- SomnoMed
- Weinmann Geräte für Medizin GmbH + Co. KG
- Whole You, Inc. (A Subsidiary of Mitsui Chemicals)

Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll